drugset / Trial / NCT02681796
Epidural Analgesia Use in Pancreatic Resections
RandomizedParallel-groupSingle-blindSupportive care
Summary
The rationale for this study is to investigate the benefits of epidural analgesia in pancreatic resections in a prospective, single blind, randomized control trial. This study will evaluate both short and long-term outcomes related to epidural analgesia, providing a longitudinal and comprehensive perspective to the advantages and disadvantages of this technique. The investigators hypothesize that the use of epidural analgesia reduces a patient's consumption of morphine or morphine-equivalent in the post-operative period following pancreatic resections.
Timeline
- Start
- 2016-06-07
- Primary completion
- 2020-02-07
- Completion
- 2020-02-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.125 % | Other |